Evidence map›Paper›PMID 21233414›Full record

ReviewJournal of leukocyte biology2011

Nitric oxide and redox mechanisms in the immune response.

David A Wink, Harry B Hines, Robert Y S Cheng, Christopher H Switzer, Wilmarie Flores-Santana, Michael P Vitek, Lisa A Ridnour, Carol A Colton

Abstract readReview
In one paragraph

Review in Journal of leukocyte biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 327 papers.

0numbers the graph read from it
0cells of the map it votes in
327citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

327 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Phenolic-Enriched Fractions ofCurrent issues in molecular biology · 2026
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

267 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

David A WinkRadiation Biology Branch, National Cancer Institute/National Institutes of Health, Bethesda, MD 20892, USA. wink@mail.nih.gov
Harry B Hines
Robert Y S Cheng
Christopher H Switzer
Wilmarie Flores-Santana
Michael P Vitek
Lisa A Ridnour
Carol A Colton

Funding

Redox Mechanism Process of Nos2 and COX2 in Stroma tumor interactionZIABC010898 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI WINK, DAVID · 2009 to 2025
$8.6M
Nitric Oxide as a Modifier of Oxidative StressZIASC007281 · NCI · DIVISION OF CLINICAL SCIENCES - NCI · PI WINK, DAVID · 2009 to 2025
$8.1M
The amyloid cascade in a novel mouse model of Alzheimer's diseaseR01AG031124 · NIA · DUKE UNIVERSITY · PI COLTON, CAROL ANNE · 2009 to 2013
$1.5M
A Mouse Model of Inflammation in Alzheimer's DiseaseR01AG031845 · NIA · DUKE UNIVERSITY · PI COLTON, CAROL ANNE · 2009 to 2013
$1.5M
NIA NIH HHS R01 AG031124NIA NIH HHS R01 AG031845
6 · The paper itself

Abstract

The role of redox molecules, such as NO and ROS, as key mediators of immunity has recently garnered renewed interest and appreciation. To regulate immune responses, these species trigger the eradication of pathogens on the one hand and modulate immunosuppression during tissue-restoration and wound-healing processes on the other. In the acidic environment of the phagosome, a variety of RNS and ROS is produced, thereby providing a cauldron of redox chemistry, which is the first line in fighting infection. Interestingly, fluctuations in the levels of these same reactive intermediates orchestrate other phases of the immune response. NO activates specific signal transduction pathways in tumor cells, endothelial cells, and monocytes in a concentration-dependent manner. As ROS can react directly with NO-forming RNS, NO bioavailability and therefore, NO response(s) are changed. The NO/ROS balance is also important during Th1 to Th2 transition. In this review, we discuss the chemistry of NO and ROS in the context of antipathogen activity and immune regulation and also discuss similarities and differences between murine and human production of these intermediates.

Indexed as

Signal TransductionAnimalsHumansImmunity, CellularNitric OxideOxidation-ReductionNitric Oxide

Identifiers

PMID21233414
PMCPMC3100761

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.